- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01948167
Bending Adolescent Depression Trajectories Through Personalized Prevention
2 mars 2021 mis à jour par: Children's Hospital of Philadelphia
Investigators will combine risk factor research and evidence-based prevention programs, to advance knowledge on personalized approaches to prevention that may be able to better "bend trajectories" of depression that surge throughout adolescence.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Investigators will innovatively combine risk factor research and evidence-based prevention programs, to advance knowledge on personalized approaches to prevention that may be able to better "bend trajectories" of depression that surge throughout adolescence.
A randomized controlled trial will examine the benefits of matching youth to two depression prevention programs of Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST) and Coping with Stress (CWS) for the prevention of depression in adolescents.
These two programs are designed to address distinct risk factors for depression - CWS addresses cognitive risks and IPT-AST addresses interpersonal risks.
A total of 210 participants across two sites, University of Denver and Rutgers University, will be stratified on cognitive and interpersonal risk and randomized to the two conditions.
The goals of the study are to (1) demonstrate that prevention programs can modify depression trajectories among youth by examining within person changes in trajectories over time (three years before and three years after the prevention programs) and by comparing trajectories of prevention youth with changes in same aged cohorts; (2) evaluate a personalized prevention approach to bending depression trajectories by matching and mismatching youth to either CWS or IPT-AST based on individual risk profiles; (3) examine mechanisms of bending depression trajectories and test whether the prevention programs operate via their hypothesized processes; and (4) explore how genetic susceptibility, emotion regulation, and temperament may affect individual response to IPT-AST and CWS.
By implementing evidence-based prevention programs after 3-years of prospective naturalistic data collection, this study will contribute essential data on personalized medicine and altering developmental trajectories of first-onset depression.
Type d'étude
Interventionnel
Inscription (Réel)
205
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Colorado
-
Denver, Colorado, États-Unis, 80208
- University of Denver
-
-
Illinois
-
Champaign, Illinois, États-Unis, 61820
- University of Illinois Urbana Champaign
-
-
New Jersey
-
Piscataway, New Jersey, États-Unis, 08854
- Rutgers University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19146
- Children's Hospital of Philadelphia
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
12 ans à 17 ans (Enfant)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Currently in the 6th to 11th grades
- Adolescent and parent must be English-speaking
- Parental consent and adolescent consent
Exclusion Criteria:
- Presence of current Major Depressive Disorder, dysthymia, bipolar disorder, or significant psychosis
- Suicide attempt in the past week or significant suicidal ideation in the past week
- Presence of significant psychopathology or significant pervasive developmental delays that would make the group inappropriate
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Interpersonal Psychotherapy- Adolescent Skills Training
|
A group prevention program that includes a 60-minute pre-group session, 8 weekly 90-minute group sessions, a 60-minute mid-group session, and 3 60-minute booster sessions.
IPT-AST focuses on psychoeducation and interpersonal skill-building to decrease interpersonal conflict and increase interpersonal support and competence.
Autres noms:
|
|
Expérimental: Coping with Stress
|
A group prevention program that consists of 8 acute 90-minute group sessions, 2 parent group sessions, and 3 continuation sessions lasting 60 minutes each.
Participants are taught to apply cognitive techniques to their personal thoughts, with the goal of generating effective counterarguments to unrealistic negative beliefs.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Presence of a Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: Post intervention (approximately 3 months post baseline)
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
Post intervention (approximately 3 months post baseline)
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 6-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
6-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 12-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
12-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 18-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
18-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 24-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
24-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 30-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
30-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Délai: 36-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
36-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: Post intervention (approximately 3 months after baseline)
|
Self-reported depression scores
|
Post intervention (approximately 3 months after baseline)
|
|
Children's Depression Inventory (CDI)
Délai: 6-months post-intervention
|
Self-reported depression scores
|
6-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: 12-months post-intervention
|
Self-reported depression scores
|
12-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: 18-months post-intervention
|
Self-reported depression scores
|
18-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: 24-months post-intervention
|
Self-reported depression scores
|
24-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: 30-months post-intervention
|
Self-reported depression scores
|
30-months post-intervention
|
|
Children's Depression Inventory (CDI)
Délai: 36-months post-intervention
|
Self-reported depression scores
|
36-months post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Children's Global Assessment Scale (CGAS)
Délai: Post Intervention (approximately 3 months following baseline)
|
Assesses global functioning
|
Post Intervention (approximately 3 months following baseline)
|
|
Children's Global Assessment Scale (CGAS)
Délai: 6-months followup
|
Assesses global functioning
|
6-months followup
|
|
Children's Global Assessment Scale (CGAS)
Délai: 12-months followup
|
Assesses global functioning
|
12-months followup
|
|
Children's Global Assessment Scale (CGAS)
Délai: 18-months followup
|
Assesses global functioning
|
18-months followup
|
|
Children's Global Assessment Scale (CGAS)
Délai: 24-months followup
|
Assesses global functioning
|
24-months followup
|
|
Children's Global Assessment Scale (CGAS)
Délai: 30-months followup
|
Assesses global functioning
|
30-months followup
|
|
Children's Global Assessment Scale (CGAS)
Délai: 36-months followup
|
Assesses global functioning
|
36-months followup
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Jami F Young, Ph.D., Children's Hospital of Philadelphia
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 septembre 2013
Achèvement primaire (Réel)
1 août 2019
Achèvement de l'étude (Réel)
1 août 2019
Dates d'inscription aux études
Première soumission
18 septembre 2013
Première soumission répondant aux critères de contrôle qualité
18 septembre 2013
Première publication (Estimation)
23 septembre 2013
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
4 mars 2021
Dernière mise à jour soumise répondant aux critères de contrôle qualité
2 mars 2021
Dernière vérification
1 mars 2021
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 17-013831
- R01MH077178 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .